🇺🇸 FDA
Patent

US 7427389

Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

granted A61KA61K51/0421

Quick answer

US patent 7427389 (Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes) held by Provectus Pharmatech, Inc. expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K51/0421